XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Explore which is better: real estate or stock market. Find the investment fit that aligns with your financial objectives.
28,586 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Trump appears set to scrap the memorandum of understanding with Iran, yet U.S. markets are largely muted as traders f...
Investors tracking UiPath PATH know 2027 will hinge on cloud adoption, service expansion, and pricing power. This gui...
As conflicts persist around the globe, households feel the bill. Experts say the true cost goes beyond weapons, shapi...
As the Fed hints at slower rate moves, crypto markets stir. This guide explains what the federal reserve signals good...
Brent crude sits near $72.68 a barrel on July 1, 2026, as traders weigh demand trends and ongoing supply discipline. ...
Memory names slide as risk appetite shifts toward cyclicals, but persistent supply constraints and improving contract...
Microsoft plans to cut more than 3,000 jobs in its Xbox division as part of a broader cost-reduction effort. The move...
ADP boosted its quarterly payout by 10% to $1.70, marking its 50th consecutive year of dividend growth. This mileston...
As July unfolds, investors are eyeing three powerful nuclear energy stocks as policy momentum and grid demand bolster...
February delivered the first drop in health care payrolls in more than four years, signaling a shift in a market that...
AMD faces another round of upgrades as AI infrastructure spending keeps demand alive. Analysts raise targets while in...